Improving antibiotic use in breastfeeding mothers and their infants
Optimization of Antibiotics in Mothers and their Breastfed Infants Using Pharmacomicrobiomic and Metabolomic Analyses (mPRINT P50)
This study is looking at how to make antibiotic treatments safer and more effective for breastfeeding moms and their babies by understanding how antibiotics interact with breast milk and the good bacteria in it, so that moms can get the best care while nursing.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-10907659 on NIH RePORTER |
What this research studies
This research focuses on optimizing antibiotic treatments for mothers who are breastfeeding and their infants. By analyzing the interactions between antibiotics, the microbiome, and metabolites in breast milk, the study aims to enhance the safety and effectiveness of antibiotic therapy. The approach involves advanced techniques in pharmacomicrobiomics and metabolomics to understand how these factors influence health outcomes in both mothers and their babies. Patients may benefit from tailored antibiotic therapies that consider the unique needs of breastfeeding mothers and their infants.
Who could benefit from this research
Good fit: Ideal candidates for this research include breastfeeding mothers who require antibiotic treatment and their breastfed infants.
Not a fit: Patients who are not breastfeeding or those who do not require antibiotic therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective antibiotic treatments for breastfeeding mothers and their infants.
How similar studies have performed: Previous research has shown promising results in optimizing antibiotic therapies through pharmacomicrobiomic approaches, indicating potential for success in this area.
Where this research is happening
La Jolla, United States
- University of California, San Diego — La Jolla, United States (Active)
Researchers
- Principal investigator: Tremoulet, Adriana H — University of California, San Diego
- Study coordinator: Tremoulet, Adriana H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.